NCT04903964

Brief Summary

The Effect of Individualized Nutrition Training Given to the Families of Children with Congenital Heart Disease (CHD) in the Post-Operative Period on their Growth and Development This study was conducted experimentally to determine the effects of individualized nutrition training given to mothers of children who had surgery for CHD on their growth and development.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 30, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

May 27, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2021

Completed
Last Updated

June 24, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

April 30, 2021

Last Update Submit

June 19, 2026

Conditions

Keywords

Child Health and NursingCongenital Heart DiseaseFamily Centered CareGrowth and Developmentİndividual Nutrition Education.

Outcome Measures

Primary Outcomes (1)

  • Body weight measurement of growth parameter

    In order to determine the physical growth status of the babies, kilograms (in kg) will be measured by the researcher. These measurement results will be given as average Z scores ((kg) type and percentile values. Body weight is measured on an Oncomed electronic scale by removing the clothing and subtracting the dry weight of the ultra-prima brand diaper.

    every weeek up to 1 months

Secondary Outcomes (2)

  • Height measurement of growth parameter

    every weeek up to 1 months

  • Head circumference measurement of growth parameters

    every weeek up to 1 months

Study Arms (3)

Experimental Group 1: Orally Fed Group Receiving Individualized Nutrition Education

EXPERIMENTAL

This group consisted of children aged 0-3 years with congenital heart disease who were fed orally according to their age and clinical condition. A researcher-developed questionnaire, anthropometric growth measurements (body weight, height, head circumference, and chest circumference), and the Ankara Developmental Screening Inventory (ADSI/AGTE) were administered to the children and their families. Mothers received individualized family-centered nutrition education prepared by the researcher, including breastfeeding, complementary feeding, age-appropriate nutrition, and nutritional requirements after congenital heart surgery. Following the educational intervention, anthropometric measurements were repeated on postoperative day 1, day 7, and day 14 to evaluate growth outcomes. Developmental status was assessed using the Ankara Developmental Screening Inventory.

Other: family-centered nutrition education

Experimental Group 2: Nutrition Education Plus Nutritional Support Group

EXPERIMENTAL

Arm/Group Description: This group consisted of children aged 0-3 years with congenital heart disease who received individualized nutrition education in addition to nutritional support, including fortified breast milk, oral nutritional supplements, and/or enteral nutritional support according to their nutritional requirements. A researcher-developed questionnaire, anthropometric growth measurements (body weight, height, head circumference, and chest circumference), and the Ankara Developmental Screening Inventory (ADSI/AGTE) were administered to the children and their families. Mothers received individualized family-centered nutrition education prepared by the researcher. Following the intervention, anthropometric measurements were repeated on postoperative day 1, day 7, and day 14 to evaluate growth outcomes. Developmental status was assessed using the Ankara Developmental Screening Inventory.

Other: family-centered nutrition education

control group

NO INTERVENTION

While collecting research data on the specified dates; Comparison group (KG) will be selected as many as the number of volunteers who want to participate in the research. No nutritional attempt will be made to the child included in this group. The parameters used in the evaluation of growth (height, head and chest circumference measurement) and the Ankara Development Screening Inventory (AGTE) will be applied to children aged 0-3 who are followed up due to congenital heart disease.

Interventions

There is a training program prepared by the researcher to increase the nutritional knowledge of mothers with children aged 0-3. The definition and importance of nutrition in the session, respectively, adequate and balanced nutrition, insufficient and unbalanced nutrition damages, grouping of nutrients, feeding 0--6 months old baby, feeding premature baby, breastfeeding, situations to be considered while breastfeeding, starting additional foods, 9-12 monthly baby nutrition, 1-3 years old child nutrition and nutritional nutrition support.

Experimental Group 1: Orally Fed Group Receiving Individualized Nutrition EducationExperimental Group 2: Nutrition Education Plus Nutritional Support Group

Eligibility Criteria

Age30 Days - 3 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Congenital heart disease,
  • Born on time (38-42 weeks)
  • Over 2.300 gr.
  • fed with additional nutritional support to oral and oral nutrition,
  • Decided to have surgery,
  • years old,
  • The children and their families who were followed up in the post-operative service were included.

You may not qualify if:

  • No congenital heart disease
  • Not planned to have surgery,
  • over 3 years old,
  • Children with additional congenital malformation, dysmorphic syndrome, chromosomal disease, severe infection, hypothyroidism and similar disorders that may cause growth and development retardation were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Çukurova Üniversitesi Balcalı Hastanesi

Adana, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • EMEL YÜRÜK

    ÇUKUROVA ÜNİVERİSTESİ

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: The research is a randomized controlled experimental study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

April 30, 2021

First Posted

May 27, 2021

Study Start

January 20, 2021

Primary Completion

July 15, 2021

Study Completion

September 15, 2021

Last Updated

June 24, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

planned to be completed as a thesis

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
When the thesis research is finished, it will be used for publication as an article publication
Access Criteria
2 year
More information

Locations